Rite Aid (Rite Aid) ROCE % : -137.81% (As of Aug. 2023)

View and export this data going back to 1970. Start your Free Trial

What is Rite Aid ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Rite Aid's annualized ROCE % for the quarter that ended in Aug. 2023 was -137.81%.

Rite Aid ROCE % Historical Data

The historical data trend for Rite Aid's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rite Aid ROCE % Chart

Rite Aid Annual Data

Trend

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

ROCE %

Get a 7-Day Free Trial

-6.78

2.50

1.21

-5.69

-10.24

Rite Aid Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
ROCE %	Get a 7-Day Free Trial															-18.94	-0.75	-15.43	-19.84	-137.81

Rite Aid ROCE % Calculation

Rite Aid's annualized ROCE % for the fiscal year that ended in Feb. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Feb. 2023 )		(A: Feb. 2022 )		(A: Feb. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Feb. 2023 )		(A: Feb. 2022 )		(A: Feb. 2023 )
	=	-532.004	/	( ( (8529.003 - 2933.088)	+	(7527.362 - 2727.875) )	/ 2 )
	=	-532.004	/	( (5595.915	+	4799.487)	/ 2 )
	=	-532.004	/	5197.701
	=	-10.24 %

Rite Aid's ROCE % of for the quarter that ended in Aug. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Aug. 2023 )		(Q: May. 2023 )		(Q: Aug. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Aug. 2023 )		(Q: May. 2023 )		(Q: Aug. 2023 )
	=	-3780.136	/	( ( (7650.418 - 2772.571)	+	(7125.952 - 6517.954) )	/ 2 )
	=	-3780.136	/	( ( 4877.847	+	607.998 )	/ 2 )
	=	-3780.136	/	2742.9225
	=	-137.81 %

(1) Note: The EBIT data used here is four times the quarterly (Aug. 2023) EBIT data.

Rite Aid (OTCPK:RADCQ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Rite Aid ROCE % Related Terms

Thank you for viewing the detailed overview of Rite Aid's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rite Aid (Rite Aid) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Rite Aid Corp (OTCPK:RADCQ) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

RTA1:Germany

Address

1200 Intrepid Avenue, PO Box 3165, Philadelphia, PA, USA, 17105

Website

https://www.riteaid.com

Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.

Executives

Christopher W. Dupaul	officer: Chief Operating Officer	1200 INTREPID AVENUE, 2ND FLOOR, PHILADELPHIA PA 19112
Sabatino Thomas J Jr	officer: Chief Legal Officer	C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015
Steven Bixler	officer: Chief Accounting Officer	C/O RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Heyward R Donigan	officer: Chief Executive Officer	452 DISCOVERY ROAD, VIRGINIA BEACH VA 23451
Jocelyn Z Konrad	officer: Executive VP	RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Ray Smithberger	officer: SVP, Operations	30 HUNTER LANE, CAMP HILL PA 17011
Bari A Harlam	director	C/O MOHAWK GROUP HOLDINGS, INC., 37 EAST 18TH STREET, 7TH FLOOR, NEW YORK NY 10003
Paul D Gilbert	officer: EVP, Secretary&General Counsel	103 POWELL COURT, SUITE 200, BRENTWOOD TN 37027
Andre Persaud	officer: EVP, Retail	30 HUNTER LANE, CAMP HILL PA 17011
Dan Robson	officer: President, EnvisionRXOptions	30 HUNTER LANE, CAMP HILL PA 17011
James J Peters	officer: Chief Operating Officer	C/O NXSTAGE MEDICAL, INC., 350 MERRIMACK STREET, LAWRENCE MA 01843
James J Comitale	officer: EVP, General Counsel, Secy.	30 HUNTER LANE, CAMP HILL PA 17011
Jessica Kazmaier	officer: EVP, Chief HR Officer	30 HUNTER LANE, CAMP HILL PA 17011
Justin L. Mennen	officer: EVP, Chief Information Officer	30 HUNTER LANE, CAMP HILL PA 17011
Katherine B Quinn	director	US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402